AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2021
Mar 25, 2021
31676_dirs_2021-03-25_a79f6a3b-d859-43fa-a141-389a11bb35e6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2021-03-23
Reporting Person: Marken James G. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-23 | Common Stock | A | 32041 | — | Acquired | 117338 | Direct |
Footnotes
F1: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 23, 2021.
More from ANI PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 8
Report Publication Announcement
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Investor Presentation
2026
Mar 3